+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Obesity Treatment Market by Treatment Type (Pharmacotherapy, Surgical Procedures), Drug Class (Appetite Suppressants, GLP-1 Receptor Agonists, Lipase Inhibitors), Route of Administration, Patient Age Group, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Obesity Treatment Market by Treatment Type (Pharmacotherapy, Surgical Procedures), Drug Class (Appetite Suppressants, GLP-1 Receptor Agonists, Lipase Inhibitors), Route of Administration, Patient Age Group, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Sale

Obesity Treatment Market by Treatment Type (Pharmacotherapy, Surgical Procedures), Drug Class (Appetite Suppressants, GLP-1 Receptor Agonists, Lipase Inhibitors), Route of Administration, Patient Age Group, Distribution Channel, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460255
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The obesity treatment market is evolving rapidly as global healthcare systems seek advanced, diversified, and patient-centered approaches to address rising prevalence and complex comorbidities. Decision-makers must understand both the urgency and the innovation shaping this sector to capture growth and mitigate risk in dynamic environments.

Market Snapshot: Obesity Treatment Market Growth Overview

The Obesity Treatment Market grew from USD 15.46 billion in 2024 to USD 16.69 billion in 2025. With an expected CAGR of 8.18%, the market is projected to reach USD 24.78 billion by 2030. This robust expansion is propelled by intensified focus on chronic disease management, policy shifts, and ongoing investments in pharmacotherapy, surgical advances, and digital health technologies. Escalating healthcare spending, combined with rising awareness among both clinicians and patients, continues to drive significant changes in therapeutic adoption and delivery models across global regions.

Scope & Segmentation

This research delivers comprehensive insights into the obesity treatment landscape by analyzing the following major dimensions:

  • Treatment Type: Pharmacotherapy, Surgical Procedures
  • Pharmacotherapy Categories: Over-the-counter drugs, Prescription medications
  • Surgical Procedures: Bariatric surgery, Gastric bypass, Laparoscopic surgery
  • Drug Class: Appetite suppressants, GLP-1 receptor agonists, Lipase inhibitors, Metabolism boosters
  • Route of Administration: Oral, Parenteral
  • Patient Age Group: Adults, Elderly, Pediatric
  • Distribution Channel: Offline retail, Online retail
  • End-User: Hospitals & clinics, Specialty clinics, Weight loss & wellness centers
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (covering diverse national markets), Asia-Pacific (including China, India, Japan, Australia, and other key countries)
  • Technology Coverage: Pharmacotherapy advancements, minimally invasive surgical devices, digital health platforms, and wearable patient monitoring tools
  • Competitive Landscape: In-depth review of leading companies including AbbVie Inc., Novo Nordisk A/S, Eli Lilly and Company, and additional innovators across biopharmaceutical, nutrition, and device sectors

Key Takeaways for Senior Decision-Makers

  • Multifactorial drivers—such as genetic, behavioral, and environmental factors—demand a patient-tailored approach, influencing strategic positioning across treatment continuum.
  • Breakthroughs in GLP-1 receptor agonists and integrated digital interventions are enabling new care models, improving long-term weight management and clinical outcomes.
  • Collaboration among industry leaders, digital health startups, and device manufacturers is accelerating R&D and fostering integrated, holistic care pathways.
  • Regulatory and policy environments, including reimbursement realignments and fast-track approvals, are influencing the pace of market entry and expansion for novel therapies.
  • Regional disparities in healthcare infrastructure and access to advanced treatments underscore the need for localized strategies and diversified product offerings.
  • Expanded real-time monitoring, telehealth services, and genomic analysis are supporting the shift toward precision medicine and patient empowerment within obesity management programs.

Tariff Impact and Strategic Responses

The imposition of new U.S. tariffs in 2025 has elevated supply chain costs for obesity therapeutics and devices, prompting providers and manufacturers to reevaluate sourcing, manufacturing, and procurement strategies. Cost management initiatives include bulk purchasing, localization, and formation of strategic alliances to maintain patient access and operational efficiency in a shifting trade policy environment.

Methodology & Data Sources

This report utilizes a rigorous methodology that blends primary interviews with stakeholders such as clinicians, payers, and suppliers, alongside secondary analysis of regulatory filings, clinical trial data, and scientific literature. Multi-source validation and expert panel feedback underpin each conclusion, ensuring robust and actionable insights for the obesity treatment sector.

Why This Report Matters: Strategic Advantages

  • Enables executives to benchmark opportunities and anticipate market disruptions stemming from regulatory shifts or supply chain dependencies.
  • Supports evidence-based investment, R&D prioritization, and targeted go-to-market strategies by clarifying evolving patient needs and technology adoption curves.

Aligned with the latest regional and therapeutic trends, the report aids informed decision-making for stakeholders focused on patient-centric growth.

Conclusion

Senior leaders seeking to navigate the obesity treatment market will benefit from a holistic, granular view of therapeutic advances, competitive strategies, and evolving policy realities. Proactive action in this complex landscape is essential for sustained impact and growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Widespread integration of GLP-1 receptor agonists into primary care obesity protocols
5.2. Emergence of digital therapeutics platforms offering personalized obesity management programs
5.3. Increasing use of combination pharmacotherapy targeting multiple metabolic pathways for obesity
5.4. Expansion of virtual weight loss coaching integrating AI driven behavioral change support
5.5. Rising investment in implantable neurostimulation devices for chronic weight management interventions
5.6. Growth of personalized genetic screening to guide targeted obesity therapy selection and dosing
5.7. Emerging partnerships between biopharma and tech startups to accelerate obesity treatment innovation pipelines
5.8. Expansion of insurer reimbursement models covering telehealth obesity services and remote monitoring solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Obesity Treatment Market, by Treatment Type
8.1. Introduction
8.2. Pharmacotherapy
8.2.1. Over-The-Counter Drugs
8.2.2. Prescription Medications
8.3. Surgical Procedures
8.3.1. Bariatric Surgery
8.3.2. Gastric Bypass
8.3.3. Laparoscopic Surgery
9. Obesity Treatment Market, by Drug Class
9.1. Introduction
9.2. Appetite Suppressants
9.3. GLP-1 Receptor Agonists
9.4. Lipase Inhibitors
9.5. Metabolism Boosters
10. Obesity Treatment Market, by Route of Administration
10.1. Introduction
10.2. Oral
10.3. Parenteral
11. Obesity Treatment Market, by Patient Age Group
11.1. Introduction
11.2. Adults
11.3. Elderly
11.4. Pediatric
12. Obesity Treatment Market, by Distribution Channel
12.1. Introduction
12.2. Offline Retail
12.3. Online Retail
13. Obesity Treatment Market, by End-User
13.1. Introduction
13.2. Hospitals & Clinics
13.3. Specialty Clinics
13.4. Weight Loss & Wellness Centers
14. Americas Obesity Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Obesity Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Obesity Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Apollo Endosurgery, Inc.
17.3.3. AstraZeneca PLC
17.3.4. Atkins Nutritionals, Inc.
17.3.5. BTL Aesthetics
17.3.6. C.H. Boehringer Sohn AG & Ko. KG
17.3.7. Eli Lilly and Company
17.3.8. F. Hoffmann-La Roche Ltd
17.3.9. GlaxoSmithKline plc.
17.3.10. Herbalife Ltd.
17.3.11. Johnson & Johnson Services, Inc.
17.3.12. Kellogg Company
17.3.13. Medtronic PLC
17.3.14. Merck & Co.
17.3.15. Novo Nordisk A/S
17.3.16. NutriSystem, Inc.
17.3.17. Olympus Corporation
17.3.18. Pfizer, Inc.
17.3.19. ReShape Lifesciences, Inc.
17.3.20. Rhythm Pharmaceuticals, Inc.
17.3.21. Sanofi SA
17.3.22. Takeda Pharmaceutical Company Limited
17.3.23. Viking Therapeutics, Inc.
17.3.24. VIVUS LLC
17.3.25. Zealand Pharma A/S
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OBESITY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. OBESITY TREATMENT MARKET: RESEARCHAI
FIGURE 28. OBESITY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. OBESITY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. OBESITY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OBESITY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PRESCRIPTION MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PRESCRIPTION MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GLP-1 RECEPTOR AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GLP-1 RECEPTOR AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LIPASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LIPASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OBESITY TREATMENT MARKET SIZE, BY METABOLISM BOOSTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OBESITY TREATMENT MARKET SIZE, BY METABOLISM BOOSTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OBESITY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OBESITY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OBESITY TREATMENT MARKET SIZE, BY WEIGHT LOSS & WELLNESS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OBESITY TREATMENT MARKET SIZE, BY WEIGHT LOSS & WELLNESS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 106. CANADA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 107. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 108. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 109. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. CANADA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. CANADA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. CANADA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. CANADA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 124. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 125. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. MEXICO OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. MEXICO OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 204. GERMANY OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 205. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 206. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 207. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. GERMANY OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. GERMANY OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. GERMANY OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. GERMANY OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 220. FRANCE OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 221. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 222. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 223. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. FRANCE OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. FRANCE OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 252. ITALY OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 253. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 254. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 255. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 256. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 257. ITALY OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. ITALY OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. ITALY OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. ITALY OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. ITALY OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ITALY OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 268. SPAIN OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 269. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 270. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 271. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. SPAIN OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. SPAIN OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. SPAIN OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. SPAIN OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SPAIN OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 329. DENMARK OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 330. DENMARK OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 331. DENMARK OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 332. DENMARK OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 333. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 334. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 335. DENMARK OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 336. DENMARK OBESITY TREATMENT MARKET SIZE, BY DR

Samples

Loading
LOADING...

Companies Mentioned

  • AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • AstraZeneca PLC
  • Atkins Nutritionals, Inc.
  • BTL Aesthetics
  • C.H. Boehringer Sohn AG & Ko. KG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Herbalife Ltd.
  • Johnson & Johnson Services, Inc.
  • Kellogg Company
  • Medtronic PLC
  • Merck & Co.
  • Novo Nordisk A/S
  • NutriSystem, Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • ReShape Lifesciences, Inc.
  • Rhythm Pharmaceuticals, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Viking Therapeutics, Inc.
  • VIVUS LLC
  • Zealand Pharma A/S

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.78 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Obesity Diagnosis & Treatment Market by Product Category (Digital Health Solutions, Medical Devices, Nutritional Supplements), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User, Patient Age Group, Severity Class - Global Forecast 2025-2030 - Product Image

Obesity Diagnosis & Treatment Market by Product Category (Digital Health Solutions, Medical Devices, Nutritional Supplements), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User, Patient Age Group, Severity Class - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), Drug Type (Over-The-Counter Drugs, Prescription Drugs), Route Of Administration, Drug Formulation, Distribution Channel - Global Forecast 2025-2030 - Product Image

Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), Drug Type (Over-The-Counter Drugs, Prescription Drugs), Route Of Administration, Drug Formulation, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Obesity Market Report and Forecast 2025-2034 - Product Image

Obesity Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Digital Health for Obesity - Global Strategic Business Report - Product Image

Digital Health for Obesity - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Weight Loss And Obesity Management Global Market Report 2025 - Product Image

Weight Loss And Obesity Management Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.